Additionally, CMCTs upregulate MUC-2 and sIgA levels and modulate immune cell populations, strengthening both the intestinal chemical barrier and mucosal immunity, thereby enhancing resistance to viral infection and mitigating virus-induced intestinal damage. Here, MUC2 is linked to viral infectious disease.